Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients

NCT04642378 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

149

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: iNCDSS based insulin regime
DRUG: routine insulin treatment regime

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]
[object Object]